Epigenetic Analysis in Ewing Sarcoma.

Area of Science:

• Oncology
• Genomics
• Computational Biology

Background:

• Ewing sarcoma is a highly malignant bone tumor driven by specific chromosomal translocations.
• The EWSR1-FLI1 fusion protein, a common translocation product, alters gene expression by targeting specific genomic loci.
• Understanding EWSR1-FLI1's chromatin interactions is crucial for deciphering its oncogenic mechanisms.

Purpose of the Study:

• To provide a detailed protocol for analyzing genome-wide transcription factor binding and chromatin accessibility data in Ewing sarcoma.
• To outline computational tools and statistical methods for processing and interpreting ChIP-seq and ATAC-seq data.
• To establish a framework for molecular biologists to analyze Ewing sarcoma genomic and epigenomic data.

Main Methods:

• Data quality control and adapter trimming.
• Reference genome alignment.
• Identification and annotation of transcription factor binding sites (ChIP-seq) and accessible chromatin regions (ATAC-seq).
• Motif discovery and data visualization.

Main Results:

• A comprehensive computational pipeline for analyzing ChIP-seq and ATAC-seq data from Ewing sarcoma cells.
• Demonstration of data processing steps including alignment, peak calling, and annotation.
• Provision of real-world data examples for practical application.

Conclusions:

• The described protocol enables robust analysis of genome-wide chromatin data in Ewing sarcoma.
• This analytical platform facilitates the interpretation of EWSR1-FLI1's role in oncogenesis.
• The methodology supports the development of personalized analytical pipelines for cancer research.